Literature DB >> 28093465

Neonatal Abstinence Syndrome and High School Performance.

Ju Lee Oei1,2,3, Edward Melhuish4,5,6, Hannah Uebel7, Nadin Azzam7, Courtney Breen8, Lucinda Burns8, Lisa Hilder9, Barbara Bajuk10, Mohamed E Abdel-Latif11,12, Meredith Ward7,2, John M Feller7,13, Janet Falconer14, Sara Clews14, John Eastwood7,3,15,16,17, Annie Li7, Ian M Wright4,18,19.   

Abstract

BACKGROUND AND OBJECTIVES: Little is known of the long-term, including school, outcomes of children diagnosed with Neonatal abstinence syndrome (NAS) (International Statistical Classification of Disease and Related Problems [10th Edition], Australian Modification, P96.1).
METHODS: Linked analysis of health and curriculum-based test data for all children born in the state of New South Wales (NSW), Australia, between 2000 and 2006. Children with NAS (n = 2234) were compared with a control group matched for gestation, socioeconomic status, and gender (n = 4330, control) and with other NSW children (n = 598 265, population) for results on the National Assessment Program: Literacy and Numeracy, in grades 3, 5, and 7.
RESULTS: Mean test scores (range 0-1000) for children with NAS were significantly lower in grade 3 (359 vs control: 410 vs population: 421). The deficit was progressive. By grade 7, children with NAS scored lower than other children in grade 5. The risk of not meeting minimum standards was independently associated with NAS (adjusted odds ratio [aOR], 2.5; 95% confidence interval [CI], 2.2-2.7), indigenous status (aOR, 2.2; 95% CI, 2.2-2.3), male gender (aOR, 1.3; 95% CI, 1.3-1.4), and low parental education (aOR, 1.5; 95% CI, 1.1-1.6), with all Ps < .001.
CONCLUSIONS: A neonatal diagnostic code of NAS is strongly associated with poor and deteriorating school performance. Parental education may decrease the risk of failure. Children with NAS and their families must be identified early and provided with support to minimize the consequences of poor educational outcomes.
Copyright © 2017 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2017        PMID: 28093465     DOI: 10.1542/peds.2016-2651

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  34 in total

1.  Novel biomarkers to assess in utero effects of maternal opioid use: First steps toward understanding short- and long-term neurodevelopmental sequelae.

Authors:  Laura Goetzl; Tara Thompson-Felix; Nune Darbinian; Nana Merabova; Salim Merali; Carmen Merali; Kathryne Sanserino; Tamara Tatevosian; Bruno Fant; Mathieu E Wimmer
Journal:  Genes Brain Behav       Date:  2019-06-11       Impact factor: 3.449

2.  Early Intervention Referral and Enrollment Among Infants with Neonatal Abstinence Syndrome.

Authors:  Elizabeth Peacock-Chambers; JoAnna K Leyenaar; Sheila Foss; Emily Feinberg; Donna Wilson; Peter D Friedmann; Paul Visintainer; Rachana Singh
Journal:  J Dev Behav Pediatr       Date:  2019 Jul/Aug       Impact factor: 2.225

3.  Heightened sympathetic arousal is demonstrated by skin conductance responsivity to auditory stimuli in a small cohort of neonates with opiate withdrawal.

Authors:  Christiana N Oji-Mmuo; Fumiyuki Chin Gardner; Kim K Doheny
Journal:  Brain Res Bull       Date:  2017-06-15       Impact factor: 4.077

4.  Association of prenatal opiate exposure with youth outcomes assessed from infancy through adolescence.

Authors:  Charles R Bauer; John Langer; Brittany Lambert-Brown; Seetha Shankaran; Henrietta S Bada; Barry Lester; Lynn L Lagasse; Toni Whitaker; Jane Hammond
Journal:  J Perinatol       Date:  2020-05-22       Impact factor: 2.521

5.  Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.

Authors:  Ludmila N Bakhireva; Bradley D Holbrook; Shikhar Shrestha; Yuridia Leyva; Malia Ashley; Sandra Cano; Jean Lowe; Julia M Stephen; Lawrence Leeman
Journal:  Early Hum Dev       Date:  2018-12-13       Impact factor: 2.079

6.  Surveillance, Epidemiology, and Estimated Burden of Neonatal Abstinence Syndrome, Tennessee, 2013-2016.

Authors:  Julia Brennan; Caleb Wiedeman; John R Dunn; William Schaffner; Timothy F Jones
Journal:  Public Health Rep       Date:  2019-08-07       Impact factor: 2.792

7.  Capturing the statewide incidence of neonatal abstinence syndrome in real time: the West Virginia experience.

Authors:  Amna Umer; Sean Loudin; Stefan Maxwell; Christa Lilly; Meagan E Stabler; Lesley Cottrell; Candice Hamilton; Janine Breyel; Christina Mullins; Collin John
Journal:  Pediatr Res       Date:  2018-10-04       Impact factor: 3.756

8.  Letter-in-reply.

Authors:  Hendrée E Jones; Karol Kaltenbach; Tara Benjamin; Elisha M Wachman; Kevin E O'Grady
Journal:  J Addict Med       Date:  2020 Jul/Aug       Impact factor: 3.702

9.  Educational Disabilities Among Children Born With Neonatal Abstinence Syndrome.

Authors:  Mary-Margaret A Fill; Angela M Miller; Rachel H Wilkinson; Michael D Warren; John R Dunn; William Schaffner; Timothy F Jones
Journal:  Pediatrics       Date:  2018-09       Impact factor: 7.124

Review 10.  Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid Crisis.

Authors:  Andrew E Weller; Richard C Crist; Benjamin C Reiner; Glenn A Doyle; Wade H Berrettini
Journal:  Cold Spring Harb Perspect Med       Date:  2021-03-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.